Aktuel. Ernahr. Ed. Klin. Prax. 1994; 19 (3): 155–159
The role of antioxidative vitamins in the therapy of diabetes
mellitus is of growing importance. The development of diabetic
late complications (cataract, retinopathy, nephropathy and
neuropathy and others) is associated with an increased presence
of free radicals, and therefore, elevated oxidative stress of the
human body. The aim of the present study was the evaluation of
the vitamin and selenium status of diabetics. Thirty–eight
patients of the age of 35–58 years had been diabetics for 8–27
years and their plasma concentration of haemoglobin was 6.7–7.5%.
The diabetics of type I were treated with a functional insulin
therapy with dietary restrictions, whereas the type II diabetics
received oral antidiabetica (sulfonyl urea, biguanids) and had to
comply with a fixed diet. Any supplementation of vitamins was
omitted. The nutritional intake was monitored by a weighed record
over 7 days. The plasma concentrations of vitamin A,
beta–carotone, K and E were determined by reversed–phase–PLC. For
the assessment of vitamin C concentrations, a photometric method
was used, and selenium concentrations was determined by
electrothermal atomic absorption spectrometry. Mean values of
plasma concentrations were: vitamin A 36–50 microg/dl,
beta–carotene 35–42 microg/dl, vitamin K: 0.5-0.6 ng/ml, vitamin
E: 1.1–1.6 mg/dl, selenium: 72–75 microg/l. The values of vitamin
C concentration of the diabetics type I without late
complications and of type II diabetics were at 0.8 mg/dl and,
therefore, at the borderline. Diabetics of type I with late
complications showed marginal values of 0.6 plus or minus 0.3
mg/dl. The critical value for the prevention of scorbut has been
fixed at 0.4 mg/dl. The results of this confirm the importance
and efficiency of vitamins, especially of ascorbic acid. Positive
effects of this antioxidative vitamin in respect of the
prevention of diabetic side effects and subsequent disease should
therefore be expected.